Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 126.58M | $ 10.5M | 8.3% |
3/31/2025 | $ 138.52M | $ 10.5M | 7.58% |
12/31/2024 | $ 150.73M | $ 10.5M | 6.97% |
9/30/2024 | $ 98.45M | $ 10.5M | 10.67% |
6/30/2024 | $ 108.31M | $ 10.5M | 9.7% |
3/31/2024 | $ 123.73M | $ 10.5M | 8.49% |
12/31/2023 | $ 20.99M | $ 10.5M | 50.03% |
9/30/2023 | $ 29.27M | $ 14.41M | 49.23% |
6/30/2023 | $ 24.23M | $ 14.41M | 59.46% |
3/31/2023 | $ 36.23M | $ 14.41M | 39.77% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for AVALO THERAPEUTICS INC is calculated as follows: Intangibles [ $ 16.3M ] / Assets [ $ 59.19M ]
(=) Intang. to Assets [ 27.54% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.23K |
---|---|
min | 0% |
max | 23.21% |
average | 3.99% |
median | 0.52% |
std | 6.09% |